Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign In
  • Home
  • World
    Sections
    • World Home
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    Most Read
    • Philippines secretly reinforces ship at centre of South China Sea dispute
    • US banking heir gave Trump campaign fund $50mn after ex-president’s conviction
    • US to redirect Patriot air defence orders to Ukraine
    • Birth rates in rich countries halve to hit record low
    • The man with a mission to save Emmanuel Macron’s movement
  • UK
    Sections
    • UK Home
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
    Most Read
    • Unusual burst of bets preceded Rishi Sunak’s election announcement
    • ‘Every Tory I know is angry’: betting scandal sends election campaign into ‘freefall’
    • Tory election campaign director on ‘leave’ after gambling probe
    • Bank of England holds rates at 5.25% in ‘finely balanced’ decision
    • Disenchantment with the Tories spreads to Rishi Sunak’s own seat
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Revolut seeks valuation of more than $40bn in employee share sale
    • Octopus to repay £3bn of Bulb nationalisation costs
    • KPMG to cut further 200 UK jobs amid market slowdown
    • Ocado shares plunge after Canadian grocer halts robotic warehouse build
    • Everton enters exclusive sale talks with billionaire Friedkin family
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
    Most Read
    • Revolut seeks valuation of more than $40bn in employee share sale
    • Live news: UK business activity expands at slowest pace since November
    • News updates from June 20: Rutte to become Nato head; BoE keeps interest rates on hold
    • Permira’s last-minute decision to kill the Golden Goose IPO
    • St James’s Place under scrutiny: what do its customers say?
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Brace for the most distorted election result in British history
    • The danger of deepfakes is not what you think
    • The mother of all US presidential debates
    • Zero-hours contracts — an obituary
    • Invested in the WFH argument? Home in on the evidence
  • Lex
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
    Most Read
    • Making sense of Gen Z: employers seek answers on managing younger workers
    • Why tackling accent bias matters at work
    • Janus Henderson’s Ali Dibadj: ‘You’ve just got to roll with the punches’
    • Business books: what to read this month
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Where the ICC fails, others will prevail
    • Keir Starmer: ‘People need hope, but it needs to be realistic hope’
    • Best summer books of 2024: Fiction
    • The Centre Pompidou prepares for a controversial revamp
    • The FT’s guide to the best books to read this summer
  • HTSI
MenuSearch
  • Home
  • World
  • UK
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Lex
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Coronavirus

  • Tuesday, 18 June, 2024
    The Big Read
    The race against time to defeat mosquito-borne diseases

    Researchers are trying to tackle the threat before nature’s ‘flying needles’ become more prevalent and resistant to prevention

  • Tuesday, 18 June, 2024
    UK schools
    State schools have enough space for exodus of private pupils

    Labour’s VAT school plan would not overstretch state class sizes in England, data show

    Student taking exams
  • Friday, 14 June, 2024
    Food & Beverage
    UK manufacturers recall food products over E.coli risk

    Health authorities link outbreak to salad leaves as companies take ‘precautionary measure’ and pull items

  • Friday, 14 June, 2024
    UK political party funding
    Labour’s donations in first week of campaign nearly double Tories’

    Gifts to Sir Keir Starmer’s party pre-election top £1mn while big Conservative donors step back

    Duncan Kenworthy
  • Friday, 14 June, 2024
    Superdry PLC
    Superdry shareholders back £10mn lifeline to stave off insolvency

    Struggling retailer says approval is ‘crucial step’ for its survival

    A woman walks past a window display at a Superdry store in London
  • Monday, 10 June, 2024
    Moderna
    Moderna hails successful trial of combined Covid and flu shot

    Vaccine maker to seek approval for jab as it tries to diversify product pipeline

    A vial of a Moderna Covid-19 vaccine
  • Monday, 3 June, 2024
    More than 29,000 Covid fines issued in England and Wales

    Total court-issued penalties for breaches higher than any other crime bar motoring offences and TV licence evasion

    Social distancing rules in force in London in December 2020
  • Thursday, 23 May, 2024
    UK Covid inquiry
    UK civil servants ‘smashed to pieces’ in pandemic, says top official

    Simon Case tells inquiry it was ‘very frustrating’ to work for Boris Johnson during Covid crisis

    The Cabinet Office on Whitehall
  • Thursday, 23 May, 2024
    LexDrugs research
    Cancer vaccines are finally showing promise Premium content

    As Covid revenues slump, technology developed to fight the pandemic is having some success combating this disease

    A person looks into microscope
  • Tuesday, 21 May, 2024
    Nearly 4,000 convicted of Covid rule breaches in England since curbs ended

    Calls for amnesty intensify as total guilty verdicts over pandemic regulations in England top 27,000

    Passengers wearing face masks at Waterloo station in London in 2020
  • Sunday, 19 May, 2024
    New Covid variants stoke fears of a summer surge in cases

    So-called FLiRT strains set to test effectiveness of vaccines against latest mutations

    A fan wears a Chicago White Sox Covid-19 mask during the regular season MLB game between the Cleveland Guardians and the Chicago White Sox
  • Friday, 17 May, 2024
    Moderna
    Moderna wins Covid jab patent dispute over Pfizer and BioNTech

    Decision is a boon for the mRNA-vaccine maker in its legal fight to recoup pandemic profits from rivals

  • Thursday, 16 May, 2024
    Antibiotic resistance
    Global fight intensifies against superbug ‘menace’

    GSK joins UK government in committing £130mn to tackle growth of antimicrobial resistance

    Dame Sally Davies, UK special envoy on AMR
  • Monday, 13 May, 2024
    News in-depth
    Insurance battles over UK Covid lockdowns rage on in courts

    Businesses across hospitality sector have brought dozens of cases in bid to recover some losses

    Montage of a lady server with the British Royal crest and Allianz logo as background
  • Sunday, 12 May, 2024
    Pharmaceuticals sector
    ‘Pfizer for All’ consumer platform aims to provide post-Covid boost

    Drugmaker follows Eli Lilly in cutting out middlemen and selling directly to patients

  • Saturday, 11 May, 2024
    Europe Express
    Pluses and minuses of the EU recovery fund Premium content

    More large-scale investment programmes are possible despite the mixed results of Europe’s post-pandemic plan

    European Commission president Ursula von der Leyen and Donald Tusk, Poland’s prime minister
  • Friday, 10 May, 2024
    Novavax Inc
    Sanofi licensing deal doubles value of vaccine group Novavax

    Agreement worth up to $1.2bn includes plan for combined flu and Covid shots

    The logo of French drugmaker Sanofi on a building
  • Wednesday, 8 May, 2024
    Covid-19 vaccines
    The great pandemic vaccine bubble, charted

    Saving humanity’s a costly business

  • Wednesday, 8 May, 2024
    Disrupted Times
    Pandemic-era winners lose their lustre

    Also in this newsletter: UK expels Russian defence attaché for spying, Toyota profits drop 20%, regulatory costs hit Uber

    Woman on Peloton bike
  • Wednesday, 8 May, 2024
    AstraZeneca PLC
    AstraZeneca withdraws Covid-19 vaccine

    Anglo-Swedish drugmaker says availability of newer vaccines hit demand for jab

    A person prepares a vaccination syringe
  • Wednesday, 8 May, 2024
    Equities
    Pandemic-era winners suffer $1.5tn fall in market value

    Top 50 biggest stock gainers hit by painful decrease since the end of 2020 as lockdown trends fade

    Montage of Tesla and Zoom logos along with Elon Musk and a Peloton bike
  • Monday, 6 May, 2024
    News in-depth
    Health systems and employers count economic cost of long Covid

    Experts warn better data is required to drive policy as debilitating condition reduces workforce

    Montage of a picture of Tiko Bakhtadze, a graphic and a representation of the Sars-Cov-2 virus
  • Thursday, 25 April, 2024
    News in-depthSpecial Report
    Europe’s Climate Leaders

    Europe may be the fastest-warming continent, but its politicians are finding that climate regulations are a hard sell. This annual FT-Statista survey lists the companies that have made the most progress in cutting their carbon emissions intensity

    Massive protests and banner with the message SAVE THE PLANET
  • Monday, 22 April, 2024
    FT News Briefing podcast10 min listen
    Beijing bets on manufacturing

    Xi Jinping hopes manufacturing can offset the property slump

  • Monday, 22 April, 2024
    News in-depthCovid-19 vaccines
    Covid vaccine makers to clash in London over mRNA patent dispute

    Moderna alleges Pfizer and BioNTech infringed its patents in use of mRNA platform

    A woman receiving a dose of Moderna’s Covid vaccine
Previous page You are on page 1 Next page

Recommended

Covid-19 vaccines
Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
Coronavirus: free to read
Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence
Coronavirus tracker
ExplainerCoronavirus economic impact
Pandemic crisis: Global economic impact tracker
News in-depth
Coronavirus economic tracker: latest global fallout

Join us at an FT Live event

Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Explore all events

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookie PolicyManage CookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

Tools

PortfolioFT AppFT Digital EditionFT EditAlerts HubBusiness School RankingsSubscription ManagerNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT Live EventsFT ForumsBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2024. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

UK Edition

Subscribe for full access
  • Switch to International Edition

Top sections

  • Home
  • World
    • Israel-Hamas war
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
  • UK
    • UK Economy
    • UK Politics
    • UK Companies
    • Personal Finance
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
    • Artificial intelligence
    • Semiconductors
    • Cyber Security
    • Social Media
  • Markets
    • Alphaville
    • Markets Data
    • Cryptofinance
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Wealth Management
    • Moral Money
    • ETF Hub
    • Fund Management
    • Trading
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Lex
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Europe's Start-Up Hubs
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    • Working It
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports

FT recommends

  • Alphaville
  • FT Edit
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • Visual and data journalism
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Live Events
  • FT Forums
  • Board Director Programme
  • myFT Feed
  • Portfolio
  • FT Digital Edition
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In